MedPath

Comparison of continuous infusion of ropivacaine and fentanyl with intermittent bolus doses of ropivacaine and fentanyl for epidural labour analgesia-a randomised open label study

Phase 4
Registration Number
CTRI/2021/10/037270
Lead Sponsor
Department of Obstetrics and Gynaecology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 18-30 years term pregnancy with a singleton live fetus in vertex presentation when in active stage of labor with cervical dilation of >4cm.

Primigravida

Patient giving written informed consent

Exclusion Criteria

â??Patient refusal

â??Preeclampsia , Gestational diabetes

â??previous lower section cesarean section

â??multiple pregnancy

â??abnormal lie or placenta praevia and those with associated medical history like morbid obesity

â??bleeding disorders/anticoagulation therapy

â??severe anemia or any psychiatric or neurologic disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamic parameters will be monitored that is blood pressure, heart rate, oxygen saturationTimepoint: Baseline
Secondary Outcome Measures
NameTimeMethod
comparing the total consumption of drug, number of rescue boluses given in case of breakthrough pain(VAS3) felt by the patient ,motor bloakade by Bromage score, duration of second stage of labour, number of emergency cesarean sections, incidence of assisted/instrumental vaginal delivery and the Apgar score of neonate in each patientTimepoint: 24 hrs
© Copyright 2025. All Rights Reserved by MedPath